Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor
- 8 August 2002
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 449 (3), 229-237
- https://doi.org/10.1016/s0014-2999(02)02049-6
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Histamine H1-Receptor Activation of Nuclear Factor-κB: Roles for Gβγ- and Gαq/11-Subunits in Constitutive and Agonist-Mediated SignalingPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2001
- Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonistsEuropean Journal of Pharmacology, 2000
- 1120 Preclinical cardiovascular and CNS safety profile of desloratadine, a selective and nonsedating histamine H1-receptor antagonistJournal of Allergy and Clinical Immunology, 2000
- The assessment of antagonist potency under conditions of transient response kineticsEuropean Journal of Pharmacology, 1999
- Cloning and Functional Expression of the Human Histamine H3ReceptorPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1999
- Advancement of the Third Generation of AntihistaminesPediatric Asthma, Allergy & Immunology, 1999
- Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonistEuropean Journal of Pharmacology, 1997
- Genomic Cloning, Heterologous Expression and Pharmacological Characterization of a Human Histamine H1 ReceptorBiochemical and Biophysical Research Communications, 1993
- Molecular cloning of the human histamine H2 receptorBiochemical and Biophysical Research Communications, 1991
- Torsade de pointes after astemizole overdose.BMJ, 1986